Articles Referencing BLRX

Positive Data on BioLineRx Treatment - Analyst Blog

4/18/2013, 7:12 pm from Zacks.com in Investing, Business, Stocks

BioLineRx Ltd. ( BLRX ) recently announced encouraging results from a phase IIa study on BL-7040. BioLineRx is developing BL-7040 for the treatment of inflammatory bowel disease (IBD).... Read >>

BioLineRx to Start BL-8040 Study - Analyst Blog

4/16/2013, 7:09 pm from Zacks.com in Investing, Business, Stocks

BioLineRx ( BLRX ) recently received approval in the US for the initiation of a multi-center, open-label phase IIa study on BL-8040. BioLineRx is looking to develop BL-8040 for the... Read >>

Pipeline Setback at BioLineRx - Analyst Blog

3/25/2013, 4:29 pm from Zacks.com in Investing, Business, Stocks

BioLineRx ( BLRX ) recently announced disappointing results from an interim analysis of the phase II/III CLARITY trial of BL-1020. The company's share price was down by almost 53% on the... Read >>

BioLineRx to Initiate HCV Study - Analyst Blog

3/15/2013, 4:45 pm from Zacks.com in Investing, Business, Stocks

BioLineRx ( BLRX ) recently announced that French regulatory authorities have approved the initiation of a phase I/II trial for its oral hepatitis C virus (HCV) infection candidate,... Read >>